Cargando…

ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.

Detalles Bibliográficos
Autores principales:	Ortaboz, Damla, Çetin, Mehmed Semih, Cömert, Burak, Eşkazan, Ahmet Emre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937804/ https://www.ncbi.nlm.nih.gov/pubmed/36737174 http://dx.doi.org/10.1016/j.tranon.2023.101620

Ejemplares similares

Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021
por: Gill, Harinder, et al.
Publicado: (2023)

Incidence of the 15q+;17q- chromosome translocation in acute promyelocytic leukaemia (APL).
por: Sheer, D., et al.
Publicado: (1985)

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells
por: de Almeida, Luciana Yamamoto, et al.
Publicado: (2021)

Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO
por: Molinaro, Alessandro, et al.
Publicado: (2022)

Evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades
por: Teng-Fei, Sun, et al.
Publicado: (2022)

P493: ORAL-ATO/ATRA/ASCORBIC ACID (AAA)-BASED INDUCTION OR MAINTENANCE OF FIRST COMPLETE REMISSION IMPROVED OUTCOMES IN NEWLY DIAGNOSED APL: A MULTICENTRE ANALYSIS OF THE APL ASIAN CONSORTIUM (APLAC)
por: Gill, Harry, et al.
Publicado: (2023)

ATO/ATRA/Anthracycline-Chemotherapy Sequential Consolidation Achieves Long-Term Efficacy in Primary Acute Promyelocytic Leukemia
por: Long, Zi-Jie, et al.
Publicado: (2014)

An atypical promyelocytic sarcoma and pleural effusion in a patient with Gorham's disease: Efficiency of ATRA/ATO‐based treatment
por: Loyaux, Romain, et al.
Publicado: (2023)

Acute promyelocytic leukemia (APL): a review of the literature
por: Jimenez, Joaquin J., et al.
Publicado: (2020)

Charting a course through the acute promyelocytic leukemia (APL)-like nebula: the enigmatic cousins of APL
por: Ghiaur, Alexandra, et al.
Publicado: (2023)

UK Experience of an Alternative ATO Dosing Regimen in APL
por: Russell, Nigel, et al.
Publicado: (2020)

Thrombocytosis in a male patient with acute promyelocytic leukaemia during all-trans retinoic (ATRA) acid treatment
por: Aldapt, Mahmood B., et al.
Publicado: (2018)

Acute Promyelocytic Leukemia (APL): Comparison Between Children and Adults
por: Testi, Anna Maria, et al.
Publicado: (2014)

Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia in the Era of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO)
por: Colita, Andrei, et al.
Publicado: (2023)

Acute promyelocytic leukemia presenting as pulmonary thromboembolism: Not all APLs bleed
por: Vaid, Ashok K, et al.
Publicado: (2015)

S133: AN ENTIRELY ORAL REGIMEN OF ORAL-ATO, ATRA AND ASCORBIC ACID IN RISK-ADAPTED TREATMENT OF NEWLY-DIAGNOSED APL RESULTED IN EXCELLENT CLINICAL/MOLECULAR RESPONSES WITH DURABLE REMISSION
por: Gill, Harry, et al.
Publicado: (2023)

Penile Ulcer Atra Related in Patient with Acute Promyelocytic Leukemia
por: Yavasoglu, Irfan, et al.
Publicado: (2012)

Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β
por: Dunoyer-Geindre, Sylvie, et al.
Publicado: (2017)

Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group
por: Adès, Lionel, et al.
Publicado: (2018)

KDM3B suppresses APL progression by restricting chromatin accessibility and facilitating the ATRA-mediated degradation of PML/RARα
por: Wang, Xinrui, et al.
Publicado: (2019)

ATRA-induced bradycardia in a case of acute promyelocytic leukemia: A case report
por: Rathod, Santosh Govind, et al.
Publicado: (2022)

Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)
por: Nakamura, Nobuhiko, et al.
Publicado: (2021)

Recent advances in acute promyelocytic leukaemia
por: Ng, Chin-Hin, et al.
Publicado: (2017)

Crosstalk between hnRNP K and SET in ATRA‐induced differentiation in acute promyelocytic leukemia
por: Padovani, Karina Stringhetta, et al.
Publicado: (2021)

Lee Teng (left) and Hugh Hereward
por: CERN PhotoLab
Publicado: (1962)

APL Congress
por: Gjerløv, Per, et al.
Publicado: (1973)

APL : a short course
por: Pakin, Sandra
Publicado: (1973)

HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1)
por: Ri, Masaki, et al.
Publicado: (2021)

Distribution of Different PML/RARα bcr Isoforms in Indian Acute Promyelocytic Leukemia (APL) Patients and Clinicohematological Correlation
por: Chatterjee, Tathagata, et al.
Publicado: (2014)

Regulation of cell surface protease receptor S100A10 by retinoic acid therapy in acute promyelocytic leukemia (APL)(☆)
por: Holloway, Ryan W., et al.
Publicado: (2018)

Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells
por: Albanesi, Jacopo, et al.
Publicado: (2020)

MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model
por: Pereira-Martins, Diego A., et al.
Publicado: (2021)

RNF8 is responsible for ATRA resistance in variant acute promyelocytic leukemia with GTF2I/RARA fusion, and inhibition of the ubiquitin–proteasome pathway contributes to the reversion of ATRA resistance
por: Yan, Wenzhe, et al.
Publicado: (2019)

MicroRNA-181a-mediated downregulation of AC9 protein decreases intracellular cAMP level and inhibits ATRA-induced APL cell differentiation
por: Zhuang, L K, et al.
Publicado: (2014)

Establishment of a retinoic acid-resistant human acute promyelocytic leukaemia (APL) model in human granulocyte-macrophage colony-stimulating factor (hGM-CSF) transgenic severe combined immunodeficiency (SCID) mice.
por: Fukuchi, Y., et al.
Publicado: (1998)

APL2 in depth
por: Thomson, Norman D, et al.
Publicado: (1995)

APL 76 Conference
por: Hunter, G Truman
Publicado: (1976)

International Conference on APL
por: Van der Linden, Gijsbert
Publicado: (1980)

Role of the promyelocytic leukaemia protein in cell death regulation
por: Salomoni, P, et al.
Publicado: (2012)

1105 Chronic Kidney Disease and Invasive Pneumococcal Disease in Adults
por: Baxter, Roger, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0umomt9d79ecdc4knvmgvciqvj